2Umezawa H,Aoyagi T,Suda H,et al.Bestatin,an inhibitor of amino peptidase B.Produced by actinomycetes[J].J Antibiotics,1976,29(1):97-99.
3Look AT,Ashman RA,Shapiro LH,et al.Human myeloid plasma membrane glyeoprotein CDI3 (gpl50) is identical to aminopeptidase N[J].J Clin Invest,1989,83:1299-1307.
4Ota K,Ogawa N.Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults[J].Biomed Pharm,1990,44(2):93.
5张之南;沈悌.血液病诊断及疗效标准[M]第3版.北京:科学出版社,2007172-176.
6Look AT,Ashman RA,Shapiro LH. Human myeloid plasma membrane glycoprotein CD13 (gp150)is identical to aminopeptidase N[J].{H}Journal of Clinical Investigation,1989,(4):1299-1307.
7Umezawa H. Studies on low-molecular-weight immunomodi-fiers produced bymicroorgansms:results of ten years' effort[J].{H}Reviews of Infectious Diseases,1984,(3):412-420.
8Mathe C,Umezawa H,misset JL. Immunomodulating properties of bestatin in cancer patients:A phase II trial[J].{H}Biomedicine and Pharmacotherapy,1998,(10):379.
9Ino K,Bierman PJ,Varney ML. Monocyte activation by an oral immunomodulator (bestat-in) in lymphoma patients following autologous bone marrow transplantation[J].Cancer Immunother,1996,(4):206.
10Ozono S,Iwai A,Babayak S. Effects of bestatin on the host immunity in patients treated for urogenital cancer[J].{H}ACTA ONCOLOGICA,1990,(6):813.
